Globus Medical Stock Analysis
GMED Stock | USD 90.80 0.33 0.36% |
Globus Medical is undervalued with Real Value of 99.85 and Target Price of 97.85. The main objective of Globus Medical stock analysis is to determine its intrinsic value, which is an estimate of what Globus Medical is worth, separate from its market price. There are two main types of Globus Medical's stock analysis: fundamental analysis and technical analysis.
The Globus Medical stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Globus Medical's ongoing operational relationships across important fundamental and technical indicators.
Globus |
Globus Stock Analysis Notes
About 99.0% of the company shares are owned by institutional investors. The book value of Globus Medical was currently reported as 29.94. The company has Price/Earnings To Growth (PEG) ratio of 2.4. Globus Medical had not issued any dividends in recent years. Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 2400 people. To learn more about Globus Medical call David Paul at 610 930 1800 or check out https://www.globusmedical.com.Globus Medical Quarterly Total Revenue |
|
Globus Medical Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Globus Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Globus Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Over 99.0% of the company shares are owned by institutional investors | |
Latest headline from investors.com: Comfort Systems Stock Looks Hot As It Cools Data Centers |
Globus Medical Upcoming and Recent Events
20th of February 2024 Upcoming Quarterly Report | View | |
2nd of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
20th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Globus Largest EPS Surprises
Earnings surprises can significantly impact Globus Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2015-11-03 | 2015-09-30 | 0.25 | 0.28 | 0.03 | 12 | ||
2014-10-30 | 2014-09-30 | 0.21 | 0.24 | 0.03 | 14 | ||
2014-02-26 | 2013-12-31 | 0.22 | 0.25 | 0.03 | 13 |
Globus Medical Environmental, Social, and Governance (ESG) Scores
Globus Medical's ESG score is a quantitative measure that evaluates Globus Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Globus Medical's operations that may have significant financial implications and affect Globus Medical's stock price as well as guide investors towards more socially responsible investments.
Globus Medical Thematic Classifications
In addition to having Globus Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
ObamacareCompanies that count on Obamacare to take off | ||
Obamacare RepealLarge healthcare related equities associated with Obamacare | ||
Baby Boomer ProspectsMega stocks, funds and ETFs that tend to appeal to people considering retirement from the work force |
Globus Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Geode Capital Management, Llc | 2024-09-30 | 1.9 M | Norges Bank | 2024-06-30 | 1.8 M | Champlain Investment Partners, Llc | 2024-09-30 | 1.8 M | Gw&k Investment Management, Llc | 2024-09-30 | 1.8 M | Geneva Capital Management | 2024-09-30 | 1.6 M | Citadel Advisors Llc | 2024-09-30 | 1.6 M | William Blair Investment Management, Llc | 2024-09-30 | 1.6 M | Axa Sa | 2024-09-30 | 1.5 M | Van Berkom And Associates Inc | 2024-09-30 | 1.5 M | Vanguard Group Inc | 2024-09-30 | 10.6 M | Blackrock Inc | 2024-09-30 | 10.3 M |
Globus Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 12.32 B.Globus Profitablity
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.05 | 0.05 | |
Return On Capital Employed | 0.03 | 0.03 | |
Return On Assets | 0.03 | 0.03 | |
Return On Equity | 0.04 | 0.03 |
Management Efficiency
Globus Medical has return on total asset (ROA) of 0.0473 % which means that it generated a profit of $0.0473 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0222 %, meaning that it created $0.0222 on every $100 dollars invested by stockholders. Globus Medical's management efficiency ratios could be used to measure how well Globus Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of January 18, 2025, Return On Tangible Assets is expected to decline to 0.05. In addition to that, Return On Capital Employed is expected to decline to 0.03. At present, Globus Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 94.9 M, whereas Return On Tangible Assets are forecasted to decline to 0.05.Last Reported | Projected for Next Year | ||
Book Value Per Share | 31.82 | 33.41 | |
Tangible Book Value Per Share | 13.04 | 6.95 | |
Enterprise Value Over EBITDA | 15.79 | 13.51 | |
Price Book Value Ratio | 1.73 | 1.65 | |
Enterprise Value Multiple | 15.79 | 13.51 | |
Price Fair Value | 1.73 | 1.65 |
Globus Medical benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Technical Drivers
As of the 18th of January 2025, Globus Medical retains the Risk Adjusted Performance of 0.1946, downside deviation of 1.1, and Market Risk Adjusted Performance of 1.4. Globus Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Globus Medical value at risk, and the relationship between the jensen alpha and semi variance to decide if Globus Medical is priced fairly, providing market reflects its last-minute price of 90.8 per share. Given that Globus Medical has jensen alpha of 0.3677, we strongly advise you to confirm Globus Medical's regular market performance to make sure the company can sustain itself at a future point.Globus Medical Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Globus Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Globus Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Globus Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Globus Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Globus Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Globus Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Keith Pfeil few days ago Acquisition by Keith Pfeil of 5833 shares of Globus Medical at 49.65 subject to Rule 16b-3 | ||
Daniel Scavilla over three weeks ago Acquisition by Daniel Scavilla of 30000 shares of Globus Medical at 26.27 subject to Rule 16b-3 | ||
Kelly Huller over three months ago Acquisition by Kelly Huller of 40000 shares of Globus Medical at 53.75 subject to Rule 16b-3 | ||
Daniel Scavilla over six months ago Acquisition by Daniel Scavilla of 60000 shares of Globus Medical subject to Rule 16b-3 | ||
James Tobin over six months ago Acquisition by James Tobin of 15000 shares of Globus Medical subject to Rule 16b-3 | ||
Wolterman Dan over a year ago Acquisition by Wolterman Dan of 24025 shares of Globus Medical subject to Rule 16b-3 | ||
James Tobin over a year ago Acquisition by James Tobin of 15000 shares of Globus Medical subject to Rule 16b-3 |
Globus Medical Outstanding Bonds
Globus Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Globus Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Globus bonds can be classified according to their maturity, which is the date when Globus Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
GLOBAL PARTNERS LP Corp BondUS37954FAG90 | View | |
US37954FAJ30 Corp BondUS37954FAJ30 | View | |
US37959EAA01 Corp BondUS37959EAA01 | View | |
GL 48 15 JUN 32 Corp BondUS37959EAB83 | View | |
International Game Technology Corp BondUS460599AD57 | View | |
US37959GAA58 Corp BondUS37959GAA58 | View | |
US37959GAC15 Corp BondUS37959GAC15 | View | |
GBLATL 3125 15 JUN 31 Corp BondUS37959GAB32 | View |
Globus Medical Predictive Daily Indicators
Globus Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Globus Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Globus Medical Corporate Filings
F4 | 14th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 8th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 4th of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 25th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 20th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 8th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 5th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Globus Medical Forecast Models
Globus Medical's time-series forecasting models are one of many Globus Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Globus Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Globus Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Globus Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Globus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Globus Medical. By using and applying Globus Stock analysis, traders can create a robust methodology for identifying Globus entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.11 | 0.12 | |
Operating Profit Margin | 0.10 | 0.09 | |
Net Profit Margin | 0.09 | 0.09 | |
Gross Profit Margin | 0.75 | 0.85 |
Current Globus Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Globus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Globus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
97.85 | Buy | 15 | Odds |
Most Globus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Globus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Globus Medical, talking to its executives and customers, or listening to Globus conference calls.
Globus Stock Analysis Indicators
Globus Medical stock analysis indicators help investors evaluate how Globus Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Globus Medical shares will generate the highest return on investment. By understating and applying Globus Medical stock analysis, traders can identify Globus Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow | 150.5 M | |
Long Term Debt | 417.4 M | |
Common Stock Shares Outstanding | 114.6 M | |
Total Stockholder Equity | 4 B | |
Tax Provision | 42.5 M | |
Quarterly Earnings Growth Y O Y | 42.231 | |
Property Plant And Equipment Net | 646.9 M | |
Cash And Short Term Investments | 517.8 M | |
Cash | 467.3 M | |
Accounts Payable | 56.7 M | |
Net Debt | 53.1 M | |
50 Day M A | 83.43 | |
Total Current Liabilities | 392.3 M | |
Other Operating Expenses | 1.4 B | |
Non Current Assets Total | 3.2 B | |
Forward Price Earnings | 26.3852 | |
Non Currrent Assets Other | 78.6 M | |
Stock Based Compensation | 52.7 M |
Complementary Tools for Globus Stock analysis
When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |